Johnson Steven Andrew 5
5 · CORTEX PHARMACEUTICALS INC/DE/ · Filed Feb 2, 2010
Insider Transaction Report
Form 5
Johnson Steven Andrew
VP, Preclinical Development
Transactions
- Sale
Sale of Common Stock
2009-04-13$0.37/sh−200$74→ 350 total(indirect: By Spouse) - Sale
Sale of Common Stock
2009-04-13$0.36/sh−1,800$648→ 550 total(indirect: By Spouse) - Sale
Sale of Common Stock
2009-04-13$0.38/sh−350$133→ 0 total(indirect: By Spouse)